Spend on hypoglycaemic agents is highly variable between practices and increased expenditure per patient is not associated with better glycemic control. Whilst newer, more expensive agents have additional benefits, in individuals where these advantages are more marginal widespread use of these agents have important cost implications (Diabetic Medicine)
Diabetes News
Tag: Wales
The All‐Wales Medicines Strategy Group: 18 years’ experience of a National Medicines Optimisation Committee
Since 2002, AWMSG has acted as a national medicines optimisation committee in Wales. From the outset, pharmacists and clinical pharmacologists have collaborated closely and shared their complementary expertise to make a much greater contribution to the safe, effective, and cost‐effective use of medicines than either group could have achieved by working separately (British Journal of Clinical Pharmacology)
Diabetes Delivery Plan for Wales 2016-2020
In this refreshed diabetes delivery plan, the Welsh Government’s commitment to giving all people in Wales with diabetes the best possible care and support is confirmed. This plan sets out how the health service and its partners will deliver that commitment (Welsh Government)
Together for Health – A Diabetes Delivery Plan
A Delivery Plan up to 2016 for NHS Wales and its partners
Glycosmedia is also available as an App: